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(μ±σ) of the volume identified by image analysis on the new 
image sets and by an experienced oncologist on the original 
image sets was 0.76±0.13 measured by the Dice similarity 
criterion (DSC). 17 cases had a DSC above 0.8; 17 cases had a 
DSC between 0.8 and 0.6; 2 cases had a DSC below 0.6. The 
figure shows the CT images from three bladder cancer 
patients. The Blue contour is the CTV; green is the CTV 
produced by thresholding of the original CT images; cyan is 
the CTV produced by thresholding of the image analysis 
enhanced CT image, which shows good agreement with the 
clinical contours using the BPJ-enhanced image data. 
Conclusions: The image analysis study presented for defining 
the CTV on low contrast CT images has the potential to be 
used as part of an adaptive radiotherapy system. Such a 
simple approach was not possible on the original image set. 
Although good agreement was found between the clinical and 
image analysis defined CTV this study serves only to provide 
pilot results. More extensive validation is required using CBCT 
and more observers. 
   
EP-1239   
Hypofractionated split cours radiotherapy for elderly 
patients with prostate cancer and comorbidities 
M. Gawkowska-Suwinska1, R. Suwinski2, B. Smolska-
Ciszewska2, K. Behrent2, T. Dworzecki2, G. Plewicki2 
1Maria Sklodowska-Curie Memorial Cancer Center and 
Institute of Oncology, III Department of Radiotherapy and 
Chemotherapy, Gliwice, Poland  
2Maria Sklodowska-Curie Memorial Cancer Center and 
Institute of Oncology, II Department of Radiotherapy and 
Chemotherapy, Gliwice, Poland  
 
Purpose/Objective: Treatment of prostate cancer in frail 
elderly patients is challenging. Many of such patients are not 
candidates for surgery, brachytherapy or SBRT. 
Conventionally fractionated radiotherapy is frequently a 
choice, but duration of such treatment appears as an 
apparent challenge for frail individuals. To address these 
problems we designed a hypofractionated split course 
radiation therapy (HSC-RT) that, potentially, allows 
treatment in reduced number of fractions without 
compromising effectiveness. Because prostate cancer does 
not repopulate rapidly split course RT was allowed. Planned 
interruption may reduce acute reactions and may facilitate 
comfortable outpatient management of patients. 
Materials and Methods: Elderly frail patients with 
intermediate or high risk prostate cancer were considered as 
candidates for the present study. Radiation dose of 62,5 Gy 
in 2.5 Gy per fraction was given over 9 weeks with two 
planned gaps of 14 days each, after accumulation of 25 Gy 
and 50 Gy. Median age of the patients in the analyzed pilot 
series of 20 patients was 76 years (range 67-83), most 
patients had impaired general performance (ZUBROD 1-2) . A 
series of 130 consecutive patients (comparable risk 
characteristics, good PS, median age of 67 years) treated 
with conventionally fractionated radiotherapy (dose of 70-76 
Gy, median 74 Gy) was used for comparison of biochemical 
outcome. Neoadjuvant ADT was used in both groups. PSA 
concentration and treatment tolerance was assessed at 
follow-up. 
Results: In general, HSC-RT was well tolerated, ( the highest 
RTOG score for bladder toxicity during treatment was 1 for 
45% of patients, 2 for 15%, 3 for 5%, rectal toxicity was 
minimal with highest score 1 in 15 % of patients. There were 
not late rectal toxicity and late bladder toxicity was minima 
with highest score 1). Baseline median pretreatment PSA 
concentration was the same in both groups (15 ng/ml). 
However, in spite of planned treatment gaps, the PSA 
measurements at follow-up revealed somewhat favorable 
biochemical outcome in patients treated with HSC-RT, 
compared to those treated conventionally (CF). Median PSA 
concentration (ng/ml) at follow-up was lower in HSC-RT 
compared to CF (0.03 vs. 0.08 at 12 months; 0.03 vs. 0.13 at 
24 months; 0.01 vs. 0.22 at 36 months). Median PSA nadir was 
0.013 ng/ml for HSC-RT vs. 0,03 for CF. 
Conclusions: While the results of this study are limited by a 
small size and clinical heterogeneity of the analyzed group 
the outcome presented suggest that hypofractionated split 
course radiation therapy in frail elderly patients with 
intermediate/high risk prostate cancer is feasible and does 
not compromise biochemical control. 
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Purpose/Objective: Anatomical variation in bladder position 
and size has driven on-line IGART strategies to prevent 
geographical misses. A ‘plan of the day’ IGART approach 
improves target coverage and reduces normal tissue 
irradiation. We report on the clinical outcomes of patients 
treated in a phase 2 study with hypofractionated 
radiotherapy using this technique.  
Materials and Methods: Fifty-five patients with T2-T4aN0-2 
M0 bladder cancer not suitable for cystectomy or daily 
radiotherapy treatment were recruited between February 
2009 and March 2014. A library of 3 plans were created (using 
small, medium and large PTV) from planning CT scans 
performed at 0 and 30 minutes, treating whole (empty) 
bladder to 36Gy in 6 weekly fractions. Cone beam CT (CBCT) 
imaging was performed prior to each fraction. Appropriate 
PTV was selected from the library for treatment delivery. 
Acute toxicity was assessed weekly during radiotherapy and 
at 6 and 12 weeks using CTCAE v3.0. Late toxicity was 
assessed at 6 months and 12 months using Radiation Therapy 
Oncology Group (RTOG) grading. Local control was assessed 
at 3 months preferentially with cystoscopy, or if this was not 
possible with imaging alone (CT/MRI). Local progression free 
